Lipopolysaccharide-binding protein for use in a method of treating alzheimer's disease
US11357822B2 · kind B2 · utility
0Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 4, 2017 |
| Grant date | Jun 14, 2022 |
| Priority date | — |
| Expiry date | Oct 14, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating a subject suffering from Alzheimer's disease is provided. The method includes administering to the subject a therapeutically effective amount of lipopolysaccharide-binding protein (LBP). A composition including a therapeutically effective amount of LBP is also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.